【直报网6月24日讯】（中国医药网）近日，商务部发布了《2014年药品流通行业运行统计分析报告》，对药品流通行业整体规模、药品批发和零售企业销售和经营等情况进行了统计分析，并对行业发展的趋势进行了预测。

CNDSN June 24 news (Chinese Medicine) recently, the Ministry of Commerce released the 2014 pharmaceutical distribution industry run statistical analysis report and statistical analysis of the pharmaceutical distribution industry overall scale, pharmaceutical wholesale and retail enterprise sales and management, and the trend of development of the industry was predicted.

《报告》指出，在中国经济发展进入新常态的形势下，随着医改的不断推进深化以及相关政策的实施，药品流通市场规模稳步增长，结构调整取得积极进展。2014年药品流通行业销售总额达到15021亿元，同比增长15.2%，增速较上年下降1.5个百分点，其中药品零售市场3004亿元，增幅回落2.9个百分点。

"Report" pointed out that in China's economic development has entered a new normal situation, with the further deepening of the relevant policies and the implementation of health care and drug circulation steady growth of market size, structural adjustment achieved positive progress. 2014 pharmaceutical distribution industry total sales reached 15021_yi billion yuan, an increase of 15.2%, growth over the previous year decreased 1.5 percent, the medicine retail market 3004 billion yuan, growth dropped 2.9 percentage points.

《报告》认为，2014年，药品流通行业发展主要呈现出以下特点：行业由高速增长转向中高速增长，大型药品批发企业增速高于行业平均水平，药品零售行业销售增速明显回落，医药电子商务企业数量激增，创新服务模式成为行业发展的新引擎。

According to the "report", in 2014, the pharmaceutical distribution industry development mainly showing the following characteristics: Industry by the rapid growth to high-speed growth, the large pharmaceutical wholesale enterprises growth rate higher than the industry average, pharmaceutical retail industry sales growth rate dropped significantly, the surge in the number of medical e-commerce enterprises, innovative service models become the new engine of the development of the industry.

《报告》预计，2015年，药品流通行业销售总额将保持稳定增长，企业兼并重组和上市步伐有望加快，现代信息技术的应用将促使行业进入全面转型发展新阶段。同时，药品零售企业将面临深度变革的挑战和机遇。

The report is expected in 2015, the pharmaceutical distribution industry sales will maintain a steady growth, corporate mergers and acquisitions and the pace of listing is expected to accelerate, the application of modern information technology will lead the industry into a comprehensive restructuring and development of a new stage. At the same time, drug retail enterprises will face challenges and opportunities of deep change.

今年是商务部连续第五年发布行业年度统计分析报告。今后商务部将继续统计和发布药品流通行业基本信息。

This year is the Ministry of Commerce for fifth consecutive years, the industry's annual statistical analysis report. In the future, the Ministry of Commerce will continue to statistics and distribution of pharmaceutical circulation industry basic information.

Statistical analysis report of drug circulation industry in 2014

一、药品流通行业发展概况

The development of pharmaceutical circulation industry

（一）发展概述

(a) development overview

2014年是贯彻党的十八届三中全会精神、深化医药卫生体制改革、落实药品流通行业“十二五”发展规划纲要各项任务的关键之年。在中国经济发展进入新常态的形势下，随着医改的不断推进深化以及相关政策的实施，药品流通市场规模稳步增长，结构调整取得积极进展，行业集中度进一步提高，企业创新业务和服务模式不断出现，运营效率稳步攀升。

2014 is to implement the spirit of the Third Plenary Session of the party's eighteen, deepen the reform of the medical and health system, the implementation of the pharmaceutical circulation industry, the Twelfth Five Year Plan for the development of the key tasks of the year. In China's economic development has entered a new normal situation, with the further deepening of the relevant policies and the implementation of health care and drug circulation steady growth of market size, structural adjustment achieved positive progress, industry concentration further improve, enterprise business and service innovation pattern emerging, operational efficiency steadily.

（二）运行分析

(two) operational analysis

1、整体规模

1, the overall size

2014年药品流通市场销售规模继续提高，增长幅度有所降低。全年药品流通行业销售总额15021亿元，同比增长15.2%，增速较上年下降1.5个百分点，其中药品零售市场3004亿元，扣除不可比因素同比增长9.1%，增幅回落2.9个百分点。

In 2014, the sales volume of drug circulation market continued to increase, and the growth rate was decreased. Throughout the year the pharmaceutical distribution industry sales total 15021_yi billion yuan, year-on-year growth of 15.2%, growth over the previous year decreased 1.5 percent, the medicine retail market 3004 billion yuan, deduction can not increase of 9.1% compared to the same period than factors rate down 2.9 percentage points.

截至2013年底，全国共有药品批发企业1.49万家；药品零售连锁企业3570家、下辖门店15.82万家，零售单体药店27.44万家，零售药店门店总数达43.26万家。

As of the end of 2013, a total of 149 million pharmaceutical wholesale enterprises; pharmaceutical retail chain enterprises 3570, 15.82 million under the jurisdiction of the stores and 27.44 million retail monomer in the pharmacy, the total number of retail pharmacy stores of 43.26 million.

2、效益情况

2, benefit

2014年，全国药品流通直报企业主营业务收入11321亿元，扣除不可比因素同比增长15.4%，增幅回落1.6个百分点；实现利润总额247亿元，扣除不可比因素同比增长14.8%，增幅回落1.2个百分点；平均毛利率6.8%，同比上升0.1个百分点；平均费用率5.3%，同比上升0.2个百分点；平均利润率1.7%，与上年基本持平。

In 2014, the national drug distribution reporting enterprises the main business income of 11321 billion yuan, deduction can not increase of 15.4% compared to the same period than factors, growth rate dropped 1.6 percentage points; realized a total profit of 24.7 billion yuan, deduction can not increase of 14.8% compared to the same period than factors, growth rate dropped 1.2 percentage points; interest rate of 6.8 percent Ping Junmao, 0.1 percentage points year-on-year rise; average cost rate of 5.3%, an increase of 0.2 percentage points; 1.7% of average rate of profit, with the previous year basically flat.

3、销售品类与对象结构

3, sales category and object structure

按销售品类分类，药品类销售居主导地位，销售额占七大类医药商品销售总额的73.8%；其次为中成药类占14.6%，中药材类占4.0%、医疗器械类占3.6%、化学试剂类占1.3%、玻璃仪器类占0.2%、其他类占2.5%。

According to the sales category classification and drug sales ranking dominant position, sales accounted for 73.8% of the seven categories of medicine total sales of commodities; secondly for Chinese patent medicines accounted for 14.6%, type of medicine accounted for 4.0%, medical equipment accounted for 3.6%, chemical reagent accounted for 1.3%, glass instrument category accounted for 0.2%, other accounted for 2.5%.

据中国医药商业协会典型样本城市零售药店2014年品类销售统计，零售药店销售额中的药品（包括化学药品、中成药和中药饮片）销售占主导地位，占零售总额的78.4%；非药品销售占21.6%。

According to the China Association of pharmaceutical commercial typical samples of urban retail pharmacies 2014 category sales statistics, retail pharmacy sales of drugs (including chemical medicine and Chinese patent medicine and Chinese herbal medicine) sales accounted for a dominant position, 78.4% of total retail sales accounted for; non drug sales accounted for 21.6%.

按销售对象分类，2014年对批发企业销售额为6426亿元，占销售总额的42.8%，比上年降低0.3个百分点；纯销（包含对医疗终端、零售终端和居民的销售）为8596亿元，占销售总额的57.2%，比上年增加0.3个百分点。

According to the classification of sales targets, 2014 to sales of wholesale enterprises for 6426 billion yuan, accounted for 42.8% of total sales, 0.3 percentage point lower than the previous year, net sales, including sales of medical devices, retail terminal and residents 8596 billion yuan, accounted for 57.2% of total sales, than last year increased 0.3 percentage points.

4、销售区域结构

4, sales regional structure

2014年，全国六大区域销售总额比重分别为：华东39.1%、华北17.0%、中南21.6%、西南13.0%、东北5.1%、西北4.2%；其中华东、华北、中南三大区域销售额占到行业销售总额的77.7%，同比下降0.9个百分点。

In 2014, the proportion of total national sales of six regional respectively: Huadong 39.1%, 17.0% of North China, South 21.6%, southwest 13.0%, 5.1% in the northeast, northwest 4.2%; the East China, North China, central China region sales accounted for 77.7% of the total industry sales, down 0.9 percentage points.

2014年，销售额居前10位的省市依次为：北京、上海、广东、浙江、江苏、安徽、山东、重庆、河南、云南；10省市销售额占全国销售总额的64.3%，同比下降0.3个百分点。

2014, sales ranking top 10 provinces and cities as follows: Beijing, Shanghai, Guangdong, Zhejiang, Jiangsu, Anhui, Shandong, Chongqing, Henan, Yunnan, 10 provinces and cities sales accounted for 64.3% of the country's total sales, down 0.3 percentage points.

5、所有制结构

5, ownership structure

药品流通直报企业中，国有及国有控股药品流通企业主营业务收入7288亿元，占药品流通直报企业主营业务总收入的64.4%，实现利润140亿元，占直报企业利润总额的56.9%；股份制企业主营业务收入2756亿元，占直报企业主营业务总收入的24.3%，实现利润70亿元，占直报企业利润总额的28.1%。

Drug circulation reporting enterprises, state-owned and state holding drugs circulation enterprise main business income 7288 billion yuan, accounts for the drugs circulation direct reporting 64.4% of the total income of enterprises the main business, profit of 140 million yuan, accounting for direct reporting 56.9% of the total profit of the enterprise; joint-stock enterprises the main business income of 2756 billion yuan, accounted for direct reporting 24.3% of the total income of enterprises the main business, profit of 70 billion yuan, accounted for direct reporting 28.1% of the total profit of the enterprise.

6、配送结构

6, distribution structure

2014年，药品批发直报企业商品配送总额9460亿元，其中自有配送中心配送额占82.5%，非自有配送中心配送额占17.5%，非自有配送中心配送额占比较上年降低2.3个百分点；物流费用103亿元，其中自主配送物流费用占84.0%、委托配送物流费用占16.0%，委托配送物流费用占比较上年降低2.1个百分点。非自有配送中心配送额和委托配送物流费用占比下降是由于直报系统企业中大型药品流通企业加大自身物流建设，提高自有配送能力，减少了委托及非自有配送比例。物流费用占企业三项费用（营业费用、管理费用、财务费用）总额的18.5%，与上年相比增加了2.1个百分点，占营业费用的比例为32.2%，与上年相比增加了1.7个百分点。基本药物配送额为1374亿元，其中对本省配送金额占比87.24%，对外省配送金额占比12.76%。

In 2014, the pharmaceutical wholesale direct reporting enterprise commodity distribution total 946 billion yuan, which has its own distribution center distribution accounted for 82.5%, non own distribution center distribution accounted for 17.5%, non proportion of its own distribution center distribution amount compared with the previous year decreased by 2.3 percentage points; logistics cost 10.3 billion yuan, which independent logistics and distribution costs accounted for 84.0%, entrust delivery logistics costs accounted for 16.0%, entrust delivery logistics costs accounted for comparison over the reduction of 2.1 percentage points. Has its own distribution center distribution amount and commissioned logistics costs accounted for the ratio decline is due to the direct reporting system enterprises large pharmaceutical distribution companies to increase their own logistics construction and improve its own distribution capacity, reduce the commissioned and non owned distribution proportion. Logistics costs accounted for enterprise cost (operating expenses, 18.5% of the total administrative expenses and financial expenses), with the previous year compared to an increase of 2.1 percentage points, the proportion accounted for 32.2% of operating expenses, with the previous year compared to an increase of 1.7 percentage points. The basic drug delivery amount is 137400000000 yuan, of which the province's distribution amount accounted for 87.24%, the proportion of foreign provincial distribution amount accounted for 12.76%.

7、行业资本运作情况

7, industry capital operation

随着一心堂和柳州医药的成功上市，2014年底，药品流通上市公司达到17家，市值总值为2593亿元，平均市值为152.54亿元。市值100亿以上的企业有8家，分别是国药控股、上海医药、九州通、国药一致、华东医药、中国医药、国药股份和一心堂，其中国药控股和上海医药市值均超过400亿元。

With the success of the church and Liuzhou pharmaceutical listed, by the end of 2014, drug distribution listing Corporation reached 17, the market value of 259300000000 yuan, an average market capitalization of 15254000000 yuan. More than the market value of 100 billion enterprise has eight, Sinopharm, Shanghai pharmaceutical, Kyushu, Chinese medicine, Huadong medicine, Chinese medicine, Chinese medicine shares and bent hall, the Chinese Medicine Holdings and Shanghai pharmaceutical market are more than 400 billion yuan.

2014年17家药品流通上市公司披露的对外投资活动共有79起，涉及金额54.89亿元，与上年同期基本持平。投资活动主要体现在上市公司对区域市场的布局方面。

2014 17 drug distribution of foreign investment listing Corporation disclosed a total of 79, involving an amount of 5489000000 yuan, essentially flat with the same period last year. Investment activities are mainly reflected in the layout of the regional market in the listing Corporation.

8, the contribution to GDP, tax and employment

美容医药外包天然药物生物医药美容市场整形美容整形美容医药流通医疗器械药用玻璃瓶生物技术理发美发器产品

Cosmetic medicine, natural medicine, medicine, medicine, biological medicine, medical instrument, medical instrument, medical instrument, medical instrument, medical instrument, medical instrument, medical instrument, medical instrument, medical instrument, medical instrument, medical instrument, biological technology, plastic, plastic, plastic

2014年全国社会消费品零售总额为26.24万亿元，第三产业增加值为30.67万亿元。全年，药品流通行业销售总额占社会消费品零售总额的5.7%，占第三产业增加值的4.9%，同比分别增长和下降0.1个百分点。其中零售总额占社会消费品零售总额的1.1%，占第三产业增加值的1.0%。

2014 national total retail sales of social consumer goods for 26.24 yuan, third yuan of industrial added value of 30.67 yuan. Throughout the year, the total sales of pharmaceutical circulation industry accounted for 5.7% of total retail sales of social consumer goods, accounting for 4.9% of the third industry added value, an increase of 0.1 percentage points. Which total retail sales accounted for 1.1% of total retail sales of social consumer goods, accounting for 1% of the third industry added value.

2014年全国药品流通直报企业纳税额60.38亿元，扣除不可比因素，同比增长11.6%，全行业从业人数约为517万人。▲

2014 national drug circulation direct tax amount of 6038000000 yuan, net of non comparable factors, an increase of 11.6%, the whole industry is about 5170000 people. 3